bortezomib pharmacenter 3,5 mg por oldatos injekcióhoz
pharmacenter europe kft. - bortezomib -
irbesartan +pharma 75 mg filmtabletta
+pharma arzneimittel gmbh - irbezartán -
irbesartan +pharma 150 mg filmtabletta
+pharma arzneimittel gmbh - irbezartán -
irbesartan +pharma 300 mg filmtabletta
+pharma arzneimittel gmbh - irbezartán -
ranivisio
midas pharma gmbh - ranibizumabbal - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - szemészeti - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
irbesartan 1 a pharma 75 mg filmtabletta
1 a pharma gmbh - irbezartán -
irbesartan 1 a pharma 150 mg filmtabletta
1 a pharma gmbh - irbezartán -
irbesartan 1 a pharma 300 mg filmtabletta
1 a pharma gmbh - irbezartán -
furosemid pharmavit 40 mg tabletta
bristol-myers squibb pharma belgium sprl - a furoszemid -
escitalopram 1 a pharma 5 mg filmtabletta
1 a pharma gmbh - escitalopram -